These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2862296)

  • 21. [Preoperative assessment of beta adrenoceptor-blocked patients].
    Hansen PH; Carlsen JE
    Ugeskr Laeger; 1984 May; 146(19):1419-22. PubMed ID: 6151271
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
    Nakagawa Y; Sugai T; Chin WP; Shibuya T; Hashimoto K; Imai S
    Arzneimittelforschung; 1984; 34(2):194-9. PubMed ID: 6144313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 25. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.
    Leclercq JF; Rosengarten MD; Kural S; Attuel P; Coumel P
    Eur J Cardiol; 1981; 12(6):367-75. PubMed ID: 6113145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.
    Wallin JD; Shah SV
    Arch Intern Med; 1987 Apr; 147(4):654-9. PubMed ID: 2881524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamics and the state of the sympathetic-adrenal system during ketamine anesthesia in children].
    Popova TG; Ostreĭkov IF; Mikhel'son VA; Agzamkhodzhaev TS; Chetvertakov VV
    Vestn Akad Med Nauk SSSR; 1979; (9):37-41. PubMed ID: 494730
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical pharmacology of adrenergic beta-receptor blocking drugs.
    Sharma PL
    J Assoc Physicians India; 1976 Nov; 24(11):729-35. PubMed ID: 15964
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of beta-adrenergic-receptor antagonists with intrinsic sympathomimetic activity.
    Graham JA; Zanetti LA
    Am J Health Syst Pharm; 1995 Feb; 52(4):365-6. PubMed ID: 7757859
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of the adrenergic system in atherogenesis and effects of beta-blockers].
    Pauletto P; Dal Palù C
    G Ital Cardiol; 1989 Jun; 19(6):507-22. PubMed ID: 2572503
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of tranquilizing agents and cardioselective beta-receptor blockaders on cardiovascular stress reaction].
    Schierl W; Schöning M; Kinadeter H; Lohmöller G; Lydtin H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1212-5. PubMed ID: 19896
    [No Abstract]   [Full Text] [Related]  

  • 33. Haemodynamic effects of cigarette smoking during beta-adrenoceptor blockade.
    Freestone S; Ramsay LE
    Br J Clin Pharmacol; 1982 Feb; 13(2):258-60. PubMed ID: 6120715
    [No Abstract]   [Full Text] [Related]  

  • 34. [The pharmacology of beta-blockers].
    Macek K; Martínková J
    Cesk Fysiol; 1986; 35(4):306-21. PubMed ID: 2875804
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta blockers and fatigue.
    Hall PE; Kendall MJ; Smith SR
    J Clin Hosp Pharm; 1984 Dec; 9(4):283-91. PubMed ID: 6151954
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug interactions and beta blockers.
    Beeley L
    Br Med J (Clin Res Ed); 1984 Nov; 289(6455):1330-1. PubMed ID: 6149784
    [No Abstract]   [Full Text] [Related]  

  • 37. Centrally induced respiratory arrest: main cause of death in beta-adrenoceptor antagonist intoxication.
    Langemeijer JJ; de Wildt DJ; de Groot G; Sangster B
    Hum Toxicol; 1986 Jan; 5(1):65. PubMed ID: 2868988
    [No Abstract]   [Full Text] [Related]  

  • 38. Muscle cramps induced by beta-blockers with intrinsic sympathomimetic activity properties: a hint of a possible mechanism.
    Zimlichman R; Krauss S; Paran E
    Arch Intern Med; 1991 May; 151(5):1021. PubMed ID: 2025129
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents--effects on hemodynamics].
    Miyazaki M; Mitsufuji T; Yokono S
    Masui; 1985 Mar; 34(3):272-9. PubMed ID: 2862296
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.